William Richard White insider trades: Akero Therapeutics (AKRO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | AKRO | ↓ Sell | 659 | $43.02 | $28K | Direct | Sep 12, 2025 (1d) |
| Jun 18, 2025 | AKRO | ↓ Sell | 1,634 | $54.84 | $90K | Direct | Jun 20, 2025 (2d) |
| Jun 10, 2025 | AKRO | ↓ Sell | 2,804 | $53.99 | $151K | Direct | Jun 12, 2025 (2d) |
| Mar 12, 2025 | AKRO | ↓ Sell | 676 | $44.88 | $30K | Direct | Mar 14, 2025 (2d) |
| Dec 10, 2024 | AKRO | ↓ Sell | 2,817 | $30.79 | $87K | Direct | Dec 12, 2024 (2d) |
| Dec 2, 2024 | IRON | ↓ Sell | 1,957 | $64.63 | $126K | Direct | Dec 4, 2024 (2d) |
| Nov 4, 2024 | IRON | ↓ Sell | 7,337 | $58.27 | $428K | Direct | Nov 5, 2024 (1d) |
| Oct 1, 2024 | IRON | ↓ Sell | 201 | $51.31 | $10K | Direct | Oct 3, 2024 (2d) |
| Sep 10, 2024 | AKRO | ↓ Sell | 639 | $26.18 | $17K | Direct | Sep 13, 2024 (3d) |
| Sep 3, 2024 | IRON | ↓ Sell | 1,957 | $49.65 | $97K | Direct | Sep 5, 2024 (2d) |
| Aug 27, 2024 | AKRO | ↓ Sell | 98,334 | $27.02 | $2.7M | Direct | Aug 29, 2024 (2d) |
| Aug 1, 2024 | IRON | ↓ Sell | 201 | $43.44 | $9K | Direct | Aug 5, 2024 (4d) |
| Jul 25, 2024 | AKRO | ↓ Sell | 161,855 | $27.07 | $4.4M | Direct | Jul 25, 2024 (0d) |
| Jul 16, 2024 | AKRO | ↓ Sell | 34,811 | $28.04 | $976K | Direct | Jul 18, 2024 (2d) |
| Jul 1, 2024 | IRON | ↓ Sell | 201 | $46.04 | $9K | Direct | Jul 3, 2024 (2d) |
| Jun 11, 2024 | AKRO | ↓ Sell | 2,831 | $22.64 | $64K | Direct | Jun 13, 2024 (2d) |
| Jun 3, 2024 | IRON | ↓ Sell | 1,957 | $36.08 | $71K | Direct | Jun 5, 2024 (2d) |
| May 1, 2024 | IRON | ↓ Sell | 201 | $28.63 | $6K | Direct | May 3, 2024 (2d) |
| Apr 11, 2024 | IRON | ↓ Sell | 2,560 | $31.80 | $81K | Direct | Apr 15, 2024 (4d) |
| Mar 13, 2024 | AKRO | ↓ Sell | 724 | $28.33 | $21K | Direct | Mar 15, 2024 (2d) |
| Dec 14, 2023 | AKRO | ↓ Sell | 611 | $20.76 | $13K | Direct | Dec 18, 2023 (4d) |
| Dec 12, 2023 | IRON | ↓ Sell | 33,511 | $63.21 | $2.1M | Direct | Dec 14, 2023 (2d) |
| Sep 13, 2023 | AKRO | ↓ Sell | 632 | $50.34 | $32K | Direct | Sep 25, 2023 (12d) |
| Jun 20, 2023 | AKRO | ↓ Sell | 20,777 | $55.00 | $1.1M | Direct | Jun 22, 2023 (2d) |
| Jun 13, 2023 | AKRO | ↓ Sell | 606 | $55.16 | $33K | Direct | Jun 15, 2023 (2d) |
| Jan 23, 2023 | VTYX | ↓ Sell | 33,353 | $35.10 | $1.2M | Direct | Jan 24, 2023 (1d) |
| Dec 28, 2022 | AKRO | ↓ Sell | 20,000 | $49.77 | $995K | Direct | Dec 29, 2022 (1d) |
| Oct 13, 2022 | AKRO | ↓ Sell | 20,000 | $39.82 | $796K | Direct | Oct 17, 2022 (4d) |
| Sep 13, 2022 | AKRO | ↓ Sell | 32,500 | $27.03 | $878K | Direct | Sep 15, 2022 (2d) |
| Jan 14, 2022 | AKRO | ↓ Sell | 9,700 | $22.03 | $214K | Direct | Jan 18, 2022 (4d) |
| Dec 21, 2021 | AKRO | ↓ Sell | 100 | $22.00 | $2K | Direct | Dec 23, 2021 (2d) |
| Dec 17, 2021 | AKRO | ↓ Sell | 3,200 | $22.04 | $71K | Direct | Dec 20, 2021 (3d) |
| Nov 1, 2021 | AKRO | ↓ Sell | 6,500 | $22.24 | $145K | Direct | Nov 3, 2021 (2d) |
| Oct 1, 2021 | AKRO | ↓ Sell | 6,500 | $22.06 | $143K | Direct | Oct 5, 2021 (4d) |
| Sep 1, 2021 | AKRO | ↓ Sell | 8,559 | $24.00 | $205K | Direct | Sep 3, 2021 (2d) |
| Aug 2, 2021 | AKRO | ↓ Sell | 4,441 | $22.03 | $98K | Direct | Aug 4, 2021 (2d) |
| Jul 6, 2021 | AKRO | ↓ Sell | 6,500 | $24.52 | $159K | Direct | Jul 8, 2021 (2d) |
| May 3, 2021 | AKRO | ↓ Sell | 4,200 | $30.56 | $128K | Direct | May 4, 2021 (1d) |
| Apr 1, 2021 | AKRO | ↓ Sell | 50,000 | $28.64 | $1.4M | Direct | Apr 5, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William Richard White's insider trades
William Richard White is Chief Financial Officer at Akero Therapeutics (AKRO). Since Apr 1, 2021, William has reported no open-market purchases and 39 sales worth $19.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (28 filings), grants and awards (21 filings), shares returned to the company (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.